These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1860104)

  • 1. Insulin treatment, NIDDM and atherosclerosis.
    Shumak SL
    CMAJ; 1991 Jul; 145(2):134. PubMed ID: 1860104
    [No Abstract]   [Full Text] [Related]  

  • 2. [Should insulin treatment be avoided? Blood sugar is not everything in type 2 diabetes].
    Carlsen SM
    Tidsskr Nor Laegeforen; 1995 Aug; 115(18):2271-5. PubMed ID: 7652727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initiating insulin in type 2 diabetes mellitus: the earlier the better.
    Cohen O
    Isr Med Assoc J; 2004 May; 6(5):292-4. PubMed ID: 15151371
    [No Abstract]   [Full Text] [Related]  

  • 4. Beneficial effects of insulin on endothelial function, inflammation, and atherogenesis and their implications.
    Kuritzky L; Nelson SE
    J Fam Pract; 2005 Jun; 54(6):S7-9. PubMed ID: 16021783
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperinsulinemia and atherosclerosis.
    Standl E
    Clin Invest Med; 1995 Aug; 18(4):261-6. PubMed ID: 8549011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperinsulinaemia as a possible risk factor of macrovascular disease in diabetes mellitus. An overview.
    Janka HU; Standl E
    Diabete Metab; 1987 Jul; 13(3 Pt 2):279-83. PubMed ID: 3308556
    [No Abstract]   [Full Text] [Related]  

  • 7. [Insulin effect on lipidemia and immunological indices in diabetes mellitus type 1].
    Krasil'nikova EI; Blagosklonnaia IaV
    Sov Med; 1991; (5):29-32. PubMed ID: 1876915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
    Savage S; Estacio RO; Jeffers B; Schrier RW
    Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proinsulin level in diabetes mellitus measured by a new immunochemiluminometric assay.
    Wu TJ; Lin CL; Taylor RL; Kao PC
    Ann Clin Lab Sci; 1995; 25(6):467-74. PubMed ID: 8572555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with human proinsulin in eighteen patients with type I and type II diabetes mellitus.
    Thomas VA; Lamberton RP; Krauss DS; Kahn CB
    R I Med J (1976); 1991 Oct; 74(10):463-8. PubMed ID: 1957115
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes.
    Sinha A; Formica C; Tsalamandris C; Panagiotopoulos S; Hendrich E; DeLuise M; Seeman E; Jerums G
    Diabet Med; 1996 Jan; 13(1):40-6. PubMed ID: 8741811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin treatment in non-insulin dependent diabetes mellitus.
    Misra A
    Natl Med J India; 1995; 8(4):169-77. PubMed ID: 7633312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. As the worm turns. On diabetes and obesity.
    Gottlieb SH
    Diabetes Forecast; 2002 Apr; 55(4):25-7. PubMed ID: 14959687
    [No Abstract]   [Full Text] [Related]  

  • 14. Do increased proinsulin concentrations explain the excess risk of coronary heart disease in diabetic and prediabetic subjects?
    Haffner SM; Hanley AJ
    Circulation; 2002 Apr; 105(17):2008-9. PubMed ID: 11980676
    [No Abstract]   [Full Text] [Related]  

  • 15. Daily insulin dose as a predictor of macrovascular disease in insulin treated non-insulin-dependent diabetics.
    Janka HU; Ziegler AG; Standl E; Mehnert H
    Diabete Metab; 1987 Jul; 13(3 Pt 2):359-64. PubMed ID: 3308565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Insulin treatment in type 2 diabetes].
    Birkeland KI
    Tidsskr Nor Laegeforen; 2006 Mar; 126(7):919-20. PubMed ID: 16554885
    [No Abstract]   [Full Text] [Related]  

  • 17. [Insulin sensitivity in NIDDM patients with normo- and microalbuminuria].
    Trzepióra B; Pokrzywnicki W; Zelechowski M
    Wiad Lek; 1998; 51(9-10):435-40. PubMed ID: 9921108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin therapy for type 2 diabetes.
    Pergallo-Dittko V
    Diabetes Self Manag; 2003; 20(5):17, 21, 23-4. PubMed ID: 14679948
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of peroxisome proliferator-activated receptor gamma agonist treatment on subclinical atherosclerosis in patients with insulin-requiring type 2 diabetes.
    Hodis HN; Mack WJ; Zheng L; Li Y; Torres M; Sevilla D; Stewart Y; Hollen B; Garcia K; Alaupovic P; Buchanan TA
    Diabetes Care; 2006 Jul; 29(7):1545-53. PubMed ID: 16801577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the controversies of insulin therapy in patients with type 2 diabetes mellitus.
    Kuritzky L; Nelson SE
    J Fam Pract; 2005 Jun; 54(6):S3-6. PubMed ID: 16021782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.